Serine protease inhibitor A3K protects rabbit corneal endothelium from barrier function disruption induced by TNF-α

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5400-5407

  Hu, Jiaoyue ^a   Zhang, Zhenhao ^a   Xie, Hui ^a   Chen, Lelei ^a   Zhou, Yueping ^a   Chen, Wensheng ^a   Liu, Zuguo ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Barrier function; Corneal endothelium; Serine protease inhibitor A3K (SERPINA3K or SA3K); Tumor necrosis factor alpha (TNF )

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DIMETHYL SULFOXIDE; F ACTIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MYOSIN LIGHT CHAIN; PROTEIN ZO1; SERINE PROTEASE INHIBITOR A3K; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DISRUPTION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA PERMEABILITY; ESCHERICHIA COLI; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

BARRIER FUNCTION; CORNEAL ENDOTHELIUM; SERINE PROTEASE INHIBITOR A3K (SERPINA3K OR SA3K); TUMOR NECROSIS FACTOR-ALPHA (TNF-Α);

ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM, CORNEAL; INTERCELLULAR JUNCTIONS; KALLIKREINS; PROTEASE INHIBITORS; RABBITS; SERPINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881490785     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10145     Document Type: Article

References (43)

1. Bonanno JA. Molecular mechanisms underlying the corneal endothelial pump. Exp Eye Res. 2012;95:2-7.
2. Edelhauser HF. The balance between corneal transparency and edema: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006; 47:1754-1767.
3. Srinivas SP. Dynamic regulation of barrier integrity of the corneal endothelium. Optom Vis Sci. 2010;87:E239-E254.
4. Srinivas SP. Cell signaling in regulation of the barrier integrity of the corneal endothelium. Exp Eye Res. 2012;95:8-15.
5. Barry PA, Petroll WM, Andrews PM, Cavanagh HD, Jester JV. The spatial organization of corneal endothelial cytoskeletal proteins and their relationship to the apical junctional complex. Invest Ophthalmol Vis Sci. 1995;36:1115-1124.
6. Noske W, Fromm M, Levarlet B, Kreusel KM, Hirsch M. Tight junctions of the human corneal endothelium: morphological and electrophysiological features. Ger J Ophthalmol. 1994;3: 253-257.
7. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778:660-669.
8. Shivanna M, Srinivas SP. Microtubule stabilization opposes the (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium. Exp Eye Res. 2009;89:950-959.
9. Jalimarada SS, Shivanna M, Kini V, Mehta D, Srinivas SP. Microtubule disassembly breaks down the barrier integrity of corneal endothelium. Exp Eye Res. 2009;89:333-343.
10. Niederkorn JY. Immune mechanisms of corneal allograft rejection. Curr Eye Res. 2007;32:1005-1016.
11. Niederkorn JY, Mayhew E, Mellon J, Hegde S. Role of tumor necrosis factor receptor expression in anterior chamberassociated immune deviation (ACAID) and corneal allograft survival. Invest Ophthalmol Vis Sci. 2004;45:2674-2681.
12. Rayner SA, King WJ, Comer RM, et al. Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation. Clin Exp Immunol. 2000;122:109-116.
13. Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM. Anti TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol. 2005;89:533-536.
14. Elhalis H, Azizi B, Jurkunas UV. Fuchs endothelial corneal dystrophy. Ocul Surf. 2010;8:173-184.
15. Khera TK, Dick AD, Nicholson LB. Mechanisms of TNFa regulation in uveitis: focus on RNA-binding proteins. Prog Retin Eye Res. 2010;29:610-621.
16. Valentincic NV, de Groot-Mijnes JD, Kraut A, Korosec P, Hawlina M, Rothova A. Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol Vis. 2011; 17:2003-2010.
17. Maier P, Heizmann U, Bohringer D, Kern Y,Reinhard T., Predicting the risk for corneal graft rejection by aqueous humor analysis. Mol Vis. 2011;17:1016-1023
18. Maier P, Heizmann U, Bohringer D, Kern Y, Reinhard T. Distinct cytokine pattern in aqueous humor during immune reactions following penetrating keratoplasty. Mol Vis. 2010;16:53-60.
19. Watsky MA, Guan Z, Ragsdale DN. Effect of tumor necrosis factor alpha on rabbit corneal endothelial permeability. Invest Ophthalmol Vis Sci. 1996;37:1924-1929.
20. Shivanna M, Rajashekhar G, Srinivas SP. Barrier dysfunction of the corneal endothelium in response to TNF-alpha: role of p38 MAP kinase. Invest Ophthalmol Vis Sci. 2010;51:1575-1582.
21. Kimura K, Teranishi S, Fukuda K, Kawamoto K, Nishida T. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappaB. Invest Ophthalmol Vis Sci. 2008;49:565-571.
22. Shivanna M, Srinivas SP. Elevated cAMP opposes (TNF-alpha) induced loss in the barrier integrity of corneal endothelium. Mol Vis. 2010;16:1781-1790.
23. Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 2007;50:17-24.
24. Megyeri P, Nemeth L, Pabst KM, Pabst MJ, Deli MA, Abraham CS. 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-alpha-induced blood-brain barrier opening. Eur J Pharmacol. 1999;374:207-211.
25. Yin H, Gao L, Shen B, Chao L, Chao J. Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factoralpha-induced nuclear factor kappaB activation. Hypertension. 2010;56:260-267.
26. Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002;102:4751-4804.
27. Murata M, Nakagawa M, Takahashi S. Expression and distribution of kallikrein-binding protein mRNA in rat ocular tissues. Ophthalmologica. 1998;212:334-336.
28. Chao J, Chai KX, Chen LM, et al. Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J Biol Chem. 1990;265:16394-16401.
29. Gao G, Shao C, Zhang SX, Dudley A, Fant J, Ma JX. Kallikreinbinding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia. 2003;46:689-698.
30. Zhang B, Hu Y, Ma JX. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina. Invest Ophthalmol Vis Sci. 2009;50:3943-3952.
31. Zhang B, Ma JX. SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload. PLoS One. 2008;3:e4077.
32. Zhang B, Zhou KK, Ma JX. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes. 2010;59:1809-1816.
33. Liu X, Lin Z, Zhou T, et al. Anti-angiogenic and antiinflammatory effects of SERPINA3K on corneal injury. PLoS One. 2011;6:e16712.
34. Zhang B, Abreu JG, Zhou K, et al. Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proc Natl Acad Sci U S A. 2010; 107:6900-6905.
35. Bourne WM. Biology of the corneal endothelium in health and disease. Eye (Lond). 2003;17:912-918.
36. George AJ, Larkin DF. Corneal transplantation: the forgotten graft. Am J Transplant. 2004;4:678-685.
37. Fischbarg J, Diecke FP, Iserovich P, Rubashkin A. The role of the tight junction in paracellular fluid transport across corneal endothelium. Electro-osmosis as a driving force. J Membr Biol. 2006;210:117-130.
38. Kimura K, Teranishi S, Kawamoto K, Nishida T. Protective effect of dexamethasone against hypoxia-induced disruption of barrier function in human corneal epithelial cells. Exp Eye Res. 2011;92:388-393.
39. Teranishi S, Kimura K, Kawamoto K, Nishida T. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by keratinocyte growth factor. Invest Ophthalmol Vis Sci. 2008;49:2432-2437.
40. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosisindependent mechanisms. J Immunol. 2003;171:6164-6172.
41. Ramachandran C, Srinivas SP. Formation and disassembly of adherens and tight junctions in the corneal endothelium: regulation by actomyosin contraction. Invest Ophthalmol Vis Sci. 2010;51:2139-2148.
42. Ferro T, Neumann P, Gertzberg N, Clements R, Johnson A. Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol. 2000;278:L1107-L1117.
43. D'Hondt C, Srinivas SP, Vereecke J, Himpens B. Adenosine opposes thrombin-induced inhibition of intercellular calcium wave in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2007;48:1518-1527.